ArticleClinical pharmacology in drug development2022

Safety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.

Ying Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.